Profound Medical (PROF) Invested Capital (2018 - 2026)

Profound Medical's Invested Capital history runs 9 years deep, the most recent figure standing at $63.9 million for Q1 2026.

• In Q1 2026, Invested Capital rose 15.65% year-over-year to $63.9 million; the TTM figure through Mar 2026 stood at $63.9 million (up 15.65% YoY), while the FY2025 annual figure was $70.9 million, up 8.99% from the prior year.
• Invested Capital was $63.9 million for Q1 2026 at Profound Medical, down from $70.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $70.9 million in Q4 2025 to a low of $30.7 million in Q3 2024.
• Historically, Invested Capital has averaged $49.9 million across 5 years, with a median of $45.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Invested Capital tumbled 35.88% in 2023, then soared 69.81% in 2024.
• A 5-year view of Invested Capital shows it stood at $59.8 million in 2022, then slumped by 35.88% to $38.3 million in 2023, then soared by 69.81% to $65.1 million in 2024, then advanced by 8.99% to $70.9 million in 2025, then fell by 9.88% to $63.9 million in 2026.
• The last three Invested Capital figures came in at $63.9 million (Q1 2026), $70.9 million (Q4 2025), and $36.6 million (Q3 2025), per Business Quant data.